European Archives - Page 192 of 1539 - European Medical Journal

Prenatal Factors Linked to Multiple Sclerosis Risk

Find out how maternal diabetes and birth size may shape multiple sclerosis risk decades later in adulthood across large national cohorts.

WHO HIV Guidelines Reshape Treatment and Prevention

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB preventive regimens.

New Report Shows Progress and Gaps in Global Hepatitis Elimination

A new global report shows uneven progress towards viral hepatitis elimination, with major gaps in diagnosis and treatment contributing to ongoing liver-related deaths.

3D Cardiac Mapping Improves Arrhythmia Detection

Volumetric non-invasive cardiac mapping reduced geodesic localisation error by 59.3% compared with surface-only approaches, demonstrating substantially improved accuracy in identifying arrhythmia origins.

New Data Highlight Gaps in Preconception Health Support for Women

New data show that many women lack access to preconception health advice, highlighting missed opportunities to improve reproductive and pregnancy outcomes.

Hip Osteoarthritis Does Not Increase Risk of ICI Arthritis

New data show hip osteoarthritis does not raise the risk of immune checkpoint inhibitor–induced inflammatory arthritis, while ICI-related arthritis is linked to improved survival.

Dual Therapy Rivals Complex Regimens for H. pylori Eradication

A large network meta-analysis finds dual therapy for Helicobacter pylori offers comparable eradication rates with fewer side effects and better compliance than triple or quadruple regimens.

Bile Acids Linked to CKD Progression - EMJ

Altered Bile Acid Profiles Linked to Advanced Chronic Kidney Disease

Altered serum and urinary bile acids were identified in patients with advanced chronic kidney disease, with specific bile acids associated with declining kidney function.

Real-World Data Support Lebrikizumab Effectiveness in Atopic Dermatitis

Real-world data suggest lebrikizumab delivers sustained clinical and quality-of-life improvements in patients with moderate-to-severe atopic dermatitis.

New Diagnostic Tool for Coronary Microvascular Disease

New Diagnostic Tool for Coronary Microvascular Disease

In patients with non-obstructive coronary artery disease, use of IMRCT reduced CMD underdiagnosis rates from approximately 35–39% to below 6%.